Faculty and Leadership positions, Cancer Population Sciences, Comprehensive Cancer Research Consortium Bergen County, NJPosting Date: 09/30/2019
Open Faculty & Leadership Positions – Cancer Population Sciences
Newly NCI-Designated Comprehensive Cancer Research Consortium
Bergen County, NJ
The Cancer Prevention and Control Program of the Georgetown University Lombardi Comprehensive Cancer Center (LCCC) is pleased to announce multiple opportunities for investigators in cancer population sciences to join and/or lead research activities at our cancer research consortium’s campus in Bergen County, NJ at the John Theurer Cancer Center (JTCC) of Hackensack Meridian Health. These positions will include an appointment in the Georgetown University School of Medicine’s interdisciplinary Department of Oncology, with membership in and potential leadership of the LCCC Cancer Prevention and Control Program. Appointments are accompanied by significant financial resources to support faculty research.
The Cancer Prevention and Control Program has three overarching and interrelated foci: 1) identifying novel cancer risk factors and biomarkers, 2) optimizing prevention and screening efforts, and, 3) improving outcomes of cancer treatment and survivorship. Crosscutting themes include cancer health equity, clinical/translational genomics, the use of simulation modeling to inform cancer policy, and cancer and human development. A federally-funded center on tobacco product regulation is co-located in the program, along with clinical research efforts in the treatment of nicotine dependence.
About the LCCC Cancer Research Consortium – DC and NJ Campuses
Located on Georgetown University’s campus in Washington, DC, the LCCC is the only NCI-designated comprehensive cancer center in our nation’s capital. Its tripartite mission is to advance research, education, and service related to the prevention and treatment of cancer: lombardi.georgetown.edu.
The JTCC at Hackensack University Medical Center is an academic health sciences center in Bergen County, NJ and the NCIdesignated comprehensive cancer research consortium partner of the Georgetown University LCCC. Together with Hackensack Meridian Health’s Center for Discovery and Innovation, the LCCC Consortium is developing and evaluating novel cancer treatments and new approaches to prevent cancer and enhance patient outcomes. JTCC’s rapidly expanding oncology research enterprise includes innovative basic, clinical, translational, and population sciences research. As part of the LCCC Consortium, it espouses a deep commitment to conducting exceptional science across multiple programmatic and thematic areas, including molecular oncology, experimental therapeutics, breast cancer, hematologic malignancies, and cancer prevention and control. Clinically, JTCC is the topranked cancer center in NJ, the largest-volume cancer care provider in the state, and one of the largest in the US. Through shared investments, LCCC Consortium scientists are well-supported by protocol review and management systems and clinical trials offices, and have access to an impressive list of core facilities including patient/participant recruitment, survey and biospecimen collection, genomics and epigenomics, and biostatistics and bioinformatics: lombardi.georgetown.edu/research/sharedresources. This Consortium cancer center includes >125 members conducting cutting-edge research and clinical trials across the region, nationally and internationally. Combined, LCCC has access to the largest clinical network in the mid-Atlantic region. Ample opportunities exist for collaboration with researchers and clinicians across the Consortium in a highly supportive environment dedicated to the success of a cancer-focused research mission. Our Washington, DC and Bergen County, NJ campuses span a highly diverse catchment area and are focal points of cancer population sciences research. Research in the catchment area is facilitated through community-based research sites, including an office of health disparities (DC) and a center for cancer disparities (NJ).
Successful candidates will have a research doctoral or medical degree in a relevant area of public health or clinical investigation.
Applicants are required to have a strong track record of cancer-relevant publications, and to hold active federal support. Candidates who wish to be considered for program leadership are expected to have prior experience in a similar role or document high potential for developing and leading a programmatic research enterprise. The CPC Program leader in NJ will be responsible for the development, implementation, and evaluation of CPC activities at the LCCC Consortium’s NJ campus. The leader will play a highly visible role within JTCC and Consortium leadership also. Expertise in epidemiology, social/behavioral sciences, health services, symptom management, public health genomics, disparities, survivorship, and implementation science is sought, along with others.
Applicants will be carefully screened at Assistant, Associate, or Full Professor levels within Georgetown’s medical school.
To apply, please send a cover letter and CV as a single PDF to Ms. Sharon Levy (email@example.com) with “CPC Consortium
Faculty Search-NJ” in the subject line. Individual inquiries may be directed to:
Marc Schwartz, PhD
Associate Director for Population Sciences
Paula Cupertino, PhD
Director of Center for Cancer Disparities